Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 35 results.
User Information
Export Records
  1. 1.   Extracellular Matrix Limits Nanoparticle Diffusion and Cellular Uptake in a Tissue-Specific Manner
  2. Cahn,Devorah; Stern, Alexa; Buckenmeyer,Michael; Wolf,Matthew; Duncan, Gregg A
  3. ACS Nano. 2024, Nov 05;
  1. 2.   Immunological properties of silica nanoparticles: a structure-activity relationship study
  2. Grunberger, Jason William; Dobrovolskaia,Marina; Ghandehari, Hamidreza
  3. Nanotoxicology. 2024, Sep 16; 1-23.
  1. 3.   From structure to application: Progress and opportunities in peptide materials development
  2. Lopez Silva,Tania; Schneider,Joel
  3. Current Opinion in Chemical Biology. 2021, Oct; 64: 131-144.
  1. 4.   2021: an immunotherapy odyssey and the rise of nucleic acid nanotechnology
  2. Panigaj, Martin; Dobrovolskaia,Marina; Afonin, Kirill A.
  3. NANOMEDICINE. 2021, Jun 24;
  1. 5.   Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
  2. Agrawal, Mukta; Saraf, Shailendra; Saraf, Swarnlata; Dubey, Sunil K.; Puri,Anu; Gupta, Umesh; Kesharwani, Prashant; Kumar, Pramod; Naidu, V. G. M.; Murty, Upadhyayula Suryanarayana; Alexander, Amit
  3. Journal of controlled release : official journal of the Controlled Release Society. 2020, NOV 10; 327: 235-265.
  1. 6.   Nanostructured Lipid Carriers as Potential Drug Delivery Systems for Skin disorders
  2. Waghule, Tejashree; Rapalli, Vamshi Krishna; Gorantla, Srividya; Saha, Ranendra Narayan; Dubey, Sunil Kumar; Puri,Anu; Singhvi, Gautam
  3. Current pharmaceutical design. 2020, Jun 14; 26(36): 4569-4579.
  1. 7.   A cationic amphiphilic co-polymer as a carrier of nucleic acid nanoparticles (Nanps) for controlled gene silencing, immunostimulation, and biodistribution
  2. Halman, Justin R; Kim, Ki-Taek; Gwak, So-Jung; Pace, Richard; Johnson, Morgan Brittany; Chandler, Morgan R; Rackley, Lauren; Viard,Mathias; Marriott, Ian; Lee, Jeoung Soo; Afonin, Kirill A
  3. Nanomedicine : nanotechnology, biology, and medicine. 2020, Jan; 23: 102094.
  1. 8.   De novo design of selective membrane-active peptides via enzymatic control of their conformational bias on the cell surface
  2. Shi,Junfeng; Schneider,Joel
  3. Angewandte Chemie (International ed. in English). 2019, JUL 26;
  1. 9.   Subchronic and Chronic Toxicity Evaluation of Inorganic Nanoparticles for Delivery Applications
  2. Mohammadpour, Raziye; Dobrovolskaia,Marina; Cheney, Darwin L; Greish, Khaled F; Ghandehari, Hamidreza
  3. Advanced drug delivery reviews. 2019, Jul 08; 144(SI): 112-132.
  1. 10.   Cartilage-Targeted IGF-1 Treatment to Promote Longitudinal Bone Growth
  2. Lui, Julian C; Colbert, Max; Cheung, Crystal Sao Fong; Ad, Michal; Lee, Audrey; Zhu, Zhongyu; Barnes, Kevin M; Dimitrov, Dimiter S; Baron, Jeffrey
  3. Molecular therapy : the journal of the American Society of Gene Therapy. 2019, Mar 6; 27(3): 673-680.
  1. 11.   Biological scaffold-mediated delivery of myostatin inhibitor promotes a regenerative immune response in an animal model of Duchenne muscular dystrophy
  2. Estrellas, Kenneth M.; Chung, Liam; Cheug, Lindsay A.; Sadtler, Kaitlyn; Majumdar, Shoumyo; Mula,Jyothi; Wolf, Matthew T.; Elisseeff, Jennifer H.; Wagner, Kathryn R.
  3. JOURNAL OF BIOLOGICAL CHEMISTRY. 2018, OCT 5; 293(40): 15594-15605.
  1. 12.   Design and biological activity of novel stealth polymeric lipid nanoparticles for enhanced delivery of hydrophobic photodynamic therapy drugs
  2. Viard, Mathias; Reichard, Henry; Shapiro, Bruce; Durrani, Farukh A; Marko, Aimee J; Watson, R Michelle; Pandey, Ravindra K; Puri, Anu
  3. Nanomedicine : nanotechnology, biology, and medicine. 2018, Oct; 14(7): 2295-2305.
  1. 13.   Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations
  2. Shah, Ankit; Dobrovolskaia, Marina
  3. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. 2018, Apr; 14(3): 977-990.
  1. 14.   Addressing barriers to effective cancer immunotherapy with nanotechnology: Achievements, challenges, and roadmap to the next generation of nanoimmunotherapeutics
  2. Hong, Enping; Dobrovolskaia, Marina
  3. Advanced drug delivery reviews. 2018, Feb 15; 141: 3-22.
  1. 15.   Fluorous Phase-Directed Peptide Assembly Affords Nano-Peptisomes Capable of Ultrasound-Triggered Cellular Delivery
  2. Medina, Scott H; Michie, Megan S; Miller, Stephen; Schnermann, Martin; Schneider, Joel
  3. Angewandte Chemie (International ed. in English). 2017, Sep 11; 56(38): 11404-11408.
  1. 16.   Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes)
  2. Smith, B.; Lyakhov, I.; Loomis, K.; Needle, D.; Baxa, U.; Yavlovich, A.; Capala, J.; Blumenthal, R.; Puri, A.
  3. Journal of Controlled Release. 2011, Jul; 153(2): 187-194.
  1. 17.   Quantitative Analysis of Phospholipids Using Nanostructured Laser Desorption Ionization Targets
  2. Colantonio, S.; Simpson, J. T.; Fisher, R. J.; Yavlovich, A.; Belanger, J. M.; Puri, A.; Blumenthal, R.
  3. Lipids. 2011, May; 46(5): 469-477.
  1. 18.   Nanotechnology-Based Cancer Therapeutics-Promise and Challenge-Lessons Learned Through the NCI Alliance for Nanotechnology in Cancer
  2. Farrell, D.; Ptak, K.; Panaro, N. J.; Grodzinski, P.
  3. Pharmaceutical Research. 2011, Feb; 28(2): 273-278.
  1. 19.   Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications
  2. Yavlovich, A.; Smith, B.; Gupta, K.; Blumenthal, R.; Puri, A.
  3. Molecular Membrane Biology. 2010, Oct; 27(7): 364-381.
  1. 20.   Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv
  2. Loomis, K.; Smith, B.; Feng, Y.; Garg, H.; Yavlovich, A.; Campbell-Massa, R.; Dimitrov, D. S.; Blumenthal, R.; Xiao, X. D.; Puri, A.
  3. Experimental and Molecular Pathology. 2010, Apr; 88(2): 238-249.
  1. 21.   Biological Assessment of Triazine Dendrimer: Toxicological Profiles, Solution Behavior, Biodistribution, Drug Release and Efficacy in a PEGylated, Paclitaxel Construct
  2. Lo, S. T.; Stern, S.; Clogston, J. D.; Zheng, J. W.; Adiseshaiah, P. P.; Dobrovolskaia, M.; Lim, J. D.; Patri, A. K.; Sun, X. K.; Simanek, E. E.
  3. Molecular Pharmaceutics. 2010, Jul-Aug; 7(4): 993-1006.
  1. 22.   Targeting prostate cancer stem cells
  2. Crea, F.; Mathews, L. A.; Farrar, W. L.; Hurt, E. M.
  3. Anti-cancer agents in medicinal chemistry. 2009, Dec; 9(10): 1105-13.
  1. 23.   Virus maturation as a new HIV-1 therapeutic target
  2. Adamson, C. S.; Salzwedel, K.; Freed, E. O.
  3. Expert opinion on therapeutic targets. 2009, Aug; 13(8): 895-908.
  1. 24.   Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
  2. Puri, A.; Loomis, K.; Smith, B.; Lee, J. H.; Yavlovich, A.; Heldman, E.; Blumenthal, R.
  3. Critical Reviews in Therapeutic Drug Carrier Systems. 2009 26(6): 523-580.
  1. 25.   Understanding the Design Principles of Living Systems at the Nanoscale
  2. Jacobs, A.; Blumenthal, R.
  3. Current Nanoscience. 2009 5(1): 45-50.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel